Related Experiment Video

Updated: Aug 17, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Does chasing selected 'Fox' to the nucleus prevent diabetes?

Haiyan Wang1, Claes B Wollheim

  • 1Department of Cell Physiology and Metabolism, University Medical Center, CH-1211 Geneva 4, Switzerland. Haiyan.Wang@medicine.unige.ch

Trends in Molecular Medicine
|June 14, 2005
PubMed

Insights

Foxa2, a key transcription factor, is inactivated in diabetes, leading to liver issues. Restoring Foxa2 function reversed these problems, suggesting it as a target for obesity and diabetes treatments.

Area of Science:

  • Molecular biology
  • Endocrinology
  • Metabolic diseases

Background:

  • Foxa2 (Hnf3beta) is a transcription factor crucial for glucose and lipid homeostasis in the liver, pancreas, and adipocytes.
  • Hyperinsulinemia can inactivate Foxa2 through nuclear exclusion, contributing to liver steatosis and insulin resistance in diabetes models.

Purpose of the Study:

  • To investigate the role of Foxa2 inactivation in diabetes-related metabolic dysfunction.
  • To evaluate the therapeutic potential of restoring Foxa2 activity.

Main Methods:

  • Utilized three animal models of diabetes.
  • Employed adenovirus-mediated gene delivery to express a constitutively active form of Foxa2 (mutated T156 phosphorylation site).
  • Assessed effects on liver steatosis, insulin resistance, fatty acid oxidation, and biosynthesis.

Main Results:

  • Hyperinsulinemia-induced Foxa2 nuclear exclusion was linked to liver steatosis and insulin resistance.
  • Adenovirus-mediated expression of active Foxa2 corrected these abnormalities.
  • Active Foxa2 enhanced fatty acid oxidation and reduced fatty acid biosynthesis.

Conclusions:

  • Foxa2 inactivation plays a significant role in the pathogenesis of diet-induced obesity and type 2 diabetes.
  • Preventing Foxa2 phosphorylation is a potential therapeutic strategy for treating metabolic disorders like obesity and diabetes.

More Related Videos

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.